Paroxysmal Dyskinesias Revealing 3-Hydroxy-Isobutyryl-CoA Hydrolase (HIBCH) Deficiency

Abstract

Paroxysmal dyskinesias (PD) are rare movement disorders characterized by recurrent attacks of dystonia, chorea, athetosis, or their combination, with large phenotypic and genetic heterogeneity. 3-Hydroxy-isobutyryl-CoA hydrolase (HIBCH) deficiency is a neurodegenerative disease characterized in most patients by a continuous decline in psychomotor abilities or a secondary regression triggered by febrile infections and metabolic crises.

We describe two PD patients from two pedigrees, both carrying a homozygous c.913A > G, p.Thr305Ala mutation in the HIBCH gene, associated with an unusual clinical presentation. The first patient presented in the second year of life with right paroxysmal hemidystonia lasting for 30 minutes, without any loss of consciousness and without any triggering factor. The second patient has presented since the age of 3 recurrent exercise-induced PD episodes which have been described as abnormal equinovarus, contractures of the lower limbs, lasting for 1 to 4 hours, associated with choreic movements of the hands. Their neurological examination and metabolic screening were normal, while brain magnetic resonance imaging showed abnormal signal of the pallidi.

We suggest that HIBCH deficiency, through the accumulation of metabolic intermediates of the valine catabolic pathway, leads to a secondary defect in respiratory chain activity and pyruvate dehydrogenase (PDH) activity and to a broad phenotypic spectrum ranging from Leigh syndrome to milder phenotypes. The two patients presented herein expand the spectrum of the disease to include unusual paroxysmal phenotypes and HIBCH deficiency should be considered in the diagnostic strategy of PD to enable adequate preventive treatment.

Keywords

paroxysmal dyskinesias - HIBCH deficiency - mild phenotype - NGS

• References

• 1 Bhatia KP. Paroxysmal dyskinesias. Mov Disord 2011; 26 (06) 1157-1165
• 2 Méneret A, Roze E. Paroxysmal movement disorders: an update. Rev Neurol (Paris) 2016; 172 (8-9): 433-445
• 3 Erro R, Bhatia KP. Unravelling of the paroxysmal dyskinesias. J Neurol Neurosurg Psychiatry 2019; 90 (02) 227-234
• 4 Ferdinandusse S, Waterham HR, Heales SJ. et al. HIBCH mutations can cause Leigh-like disease with combined deficiency of multiple mitochondrial respiratory chain enzymes and pyruvate dehydrogenase. Orphanet J Rare Dis 2013; 8: 188
• 5 Yamada K, Naiki M, Hoshino S. et al. Clinical and biochemical characterization of 3-hydroxyisobutyryl-CoA hydrolase (HIBCH) deficiency that causes Leigh-like disease and ketoacidosis. Mol Genet Metab Rep 2014; 1: 455-460
• 6 Xu Y, Zhang J, Yu K. et al. A therapeutic regimen for 3-hydroxyisobutyryl-CoA hydrolase deficiency with exercise-induced dystonia. Eur J Paediatr Neurol 2019; 23 (05) 755-759
• 7 Schottmann G, Sarpong A, Lorenz C. et al. A movement disorder with dystonia and ataxia caused by a mutation in the HIBCH gene. Mov Disord 2016; 31 (11) 1733-1739
• 8 Broix L, Jagline H, Ivanova E. et al; Deciphering Developmental Disorders study. Mutations in the HECT domain of NEDD4L lead to AKT-mTOR pathway deregulation and cause periventricular nodular heterotopia. Nat Genet 2016; 48 (11) 1349-1358
• 9 Flicek P, Amode MR, Barrell D. et al. Ensembl 2012. Nucleic Acids Res 2012; 40 (Database issue): D84-D90
• 10 Karimzadeh P, Saberi M, Sheidaee K, Nourbakhsh M, Keramatipour M. 3-Hydroxyisobutyryl-CoA hydrolase deficiency in an Iranian child with novel HIBCH compound heterozygous mutations. Clin Case Rep 2019; 7 (02) 375-380
• 11 Peters H, Buck N, Wanders R. et al. ECHS1 mutations in Leigh disease: a new inborn error of metabolism affecting valine metabolism. Brain 2014; 137 (Pt 11): 2903-2908
• 12 Mahajan A, Constantinou J, Sidiropoulos C. ECHS1 deficiency-associated paroxysmal exercise-induced dyskinesias: case presentation and initial benefit of intervention. J Neurol 2017; 264 (01) 185-187
• 13 Olgiati S, Skorvanek M, Quadri M. et al. Paroxysmal exercise-induced dystonia within the phenotypic spectrum of ECHS1 deficiency. Mov Disord 2016; 31 (07) 1041-1048
• 14 Ogawa Y, Nakamura K, Ezawa N. et al. A novel CACNA1A nonsense variant in a patient presenting with paroxysmal exertion-induced dyskinesia. J Neurol Sci 2019; 399: 214-216